相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unification of miRNA and isomiR research: the mirGFF3 format and the mirtop API
Thomas Desvignes et al.
BIOINFORMATICS (2020)
miRDB: an online database for prediction of functional microRNA targets
Yuhao Chen et al.
NUCLEIC ACIDS RESEARCH (2020)
Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer
Katarzyna Aleksandra Kujawa et al.
CELLS (2020)
Systematic prediction of key genes for ovarian cancer by co-expression network analysis
Mingyuan Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
EMP1 Promotes the Proliferation and Invasion of Ovarian Cancer Cells Through Activating the MAPK Pathway
Yang Liu et al.
ONCOTARGETS AND THERAPY (2020)
The prognostic role of microRNA in epithelial ovarian cancer: a systematic review of literature with an overall survival meta-analysis
Patricia Ferreira et al.
Oncotarget (2020)
Identification of miRNA Master Regulators in Breast Cancer
Antonio Daniel Martinez-Gutierrez et al.
CELLS (2020)
Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned?
Ali A. Alshamrani
FRONTIERS IN ONCOLOGY (2020)
MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway
X. Y. Xia et al.
NEOPLASMA (2020)
Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer
Megan E. McDonald et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pan-cancer analysis on microRNA-associated gene activation
Hua Tan et al.
EBIOMEDICINE (2019)
Large-scale integrated analysis of ovarian cancer tumors and cell lines identifies an individualized gene expression signature for predicting response to platinum-based chemotherapy
Jie Sun et al.
CELL DEATH & DISEASE (2019)
CRM197 reverses paclitaxel resistance by inhibiting the NAC-1/Gadd45 pathway in paclitaxel-resistant ovarian cancer cells
Xiao-han Tang et al.
CANCER MEDICINE (2019)
Multi-view based integrative analysis of gene expression data for identifying biomarkers
Zi-Yi Yang et al.
SCIENTIFIC REPORTS (2019)
Comprehensive Analysis of Human microRNA-mRNA Interactome
Olga Plotnikova et al.
FRONTIERS IN GENETICS (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Discovery of HB-EGF binding peptides and their functional characterization in ovarian cancer cell lines
Yanting Shen et al.
CELL DEATH DISCOVERY (2019)
DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions
Dimitra Karagkouni et al.
NUCLEIC ACIDS RESEARCH (2018)
Cancer of the ovary, fallopian tube, and peritoneum
Jonathan S. Berek et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Integrated extracellular microRNA profiling for ovarian cancer screening
Akira Yokoi et al.
NATURE COMMUNICATIONS (2018)
MicroRNAs activate gene transcription epigenetically as an enhancer trigger
Min Xiao et al.
RNA BIOLOGY (2017)
Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase
Anna Vert et al.
ONCOTARGET (2017)
MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine
Carlos Palma Flores et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer
Kira Philipsen Prahm et al.
PLOS ONE (2017)
Integration of MicroRNA, mRNA, and Protein Expression Data for the Identification of Cancer-Related MicroRNAs
Jiyoun Seo et al.
PLOS ONE (2017)
The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication
Wensheng Zhang et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2016)
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study
Marina Bagnoli et al.
LANCET ONCOLOGY (2016)
High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both In Vivo and In Vitro
Fan Wang et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Estrogen receptor-mediated miR-486-5p regulation of OLFM4 expression in ovarian cancer
Hanyu Ma et al.
ONCOTARGET (2016)
Danish Gynecological Cancer Database
Sarah Mejer Sorensen et al.
CLINICAL EPIDEMIOLOGY (2016)
Discovery of microarray-identified genes associated with ovarian cancer progression
Xia Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
DIANA-miRPath v3.0: deciphering microRNA function with experimental support
Ioannis S. Vlachos et al.
NUCLEIC ACIDS RESEARCH (2015)
Challenges in Using Circulating miRNAs as Cancer Biomarkers
Paola Tiberio et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer
Yan Sun et al.
CHINESE JOURNAL OF CANCER (2015)
Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes
I. Shapira et al.
BRITISH JOURNAL OF CANCER (2014)
Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer
Da Yang et al.
CANCER CELL (2013)
The shaping and functional consequences of the microRNA landscape in breast cancer
Heidi Dvinge et al.
NATURE (2013)
Analysis of microRNA-target interactions across diverse cancer types
Anders Jacobsen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
Maria D. Paraskevopoulou et al.
NUCLEIC ACIDS RESEARCH (2013)
Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset
Elodie Ducros et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Integrated Analyses of microRNAs Demonstrate Their Widespread Influence on Gene Expression in High-Grade Serous Ovarian Carcinoma
Chad J. Creighton et al.
PLOS ONE (2012)
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
Jaime Prat
VIRCHOWS ARCHIV (2012)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
miRTarBase: a database curates experimentally validated microRNA-target interactions
Sheng-Da Hsu et al.
NUCLEIC ACIDS RESEARCH (2011)
Time to Recurrence and Survival in Serous Ovarian Tumors Predicted from Integrated Genomic Profiles
Parminder K. Mankoo et al.
PLOS ONE (2011)
MicroRNA-205-Directed Transcriptional Activation of Tumor Suppressor Genes in Prostate Cancer
Shahana Majid et al.
CANCER (2010)
The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
Kimberly E. Resnick et al.
GYNECOLOGIC ONCOLOGY (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
Alexandros Laios et al.
MOLECULAR CANCER (2008)
MicroRNA-373 induces expression of genes with complementary promoter sequences
Robert F. Place et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
miRBase: microRNA sequences, targets and gene nomenclature
Sam Griffiths-Jones et al.
NUCLEIC ACIDS RESEARCH (2006)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
分享论文
